Journal Information
Share
Share
Download PDF
More article options
EDITORIAL
Full text access
Pre-proof, online 12 March 2025
Post-TB Lung Disease: where are we to respond to this priority?
Visits
40
Denise Rossato Silva1, Emanuele Pontali2, Yousra Kherabi3,4, Lia D’Ambrosio5, Rosella Centis6, Giovanni Battista Migliori6,
Corresponding author
giovannibattista.migliori@icsmaugeri.it

Address for correspondence: Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Via Roncaccio 16, Tradate, Varese, 21049, Italy
1 Faculdade de Medicina, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brasil
2 Department of Infectious Diseases, Galliera Hospital, Genoa, Italy
3 Infectious and Tropical Diseases Department, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France
4 Université Paris Cité, Inserm, IAME, Paris, France
5 Public Health Consulting Group, Lugano, Switzerland
6 Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy
This item has received
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?